DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings (NCT01434355) | Clinical Trial Compass
CompletedNot Applicable
DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings
United States932 participantsStarted 2011-11-01
Plain-language summary
This research trial studies deoxyribonucleic acid (DNA) samples from younger patients with germ cell tumor and their parents or siblings. Studying samples of tumor tissue and saliva from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
Who can participate
Age range19 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The patient is enrolled on COG-ACCRN07
* The patient has a primary diagnosis of germ cell tumor (GCT) including germinoma (ICCC 9060-9065) teratoma (9080-9084), embryonal carcinoma (9070-9072), yolk sac tumor (9071),choriocarcinoma (9100, 9103, 9104), and mixed GCT (9085, 9101, 9102, 9105) in all sites including the brain and central nervous system and registered with Children's Oncology Group (COG) by a North American member institution
* The patient must be diagnosed with a germ cell tumor between July 1, 2008 and December 31, 2015
* The patient must be \< 20 years of age at the time of diagnosis
* The patient must have at least one biological parent alive and willing to participate
* In the event that one case parent cannot contribute DNA, a case sibling, defined as the biological brother or sister of the study subject, may donate instead
* All questionnaire respondents must understand English or Spanish
* Concomitant treatment on a therapeutic trial is not required
What they're measuring
1
Pediatric GCT associated with genetic susceptibility